Also, Baumgartner et al. reported a higher level of NF-κB activity in both de novo and relapsed patients with AML (35 patients) compared with controls with no correlation between CD34+ and CD34- blasts [49]. Here, NFKB1 is linked to acute myeloid leukemia.